Huge news today at Isomorphic Labs!
We have secured $2.1 Billion investment to advance the most important mission that AI can unlock: to change the way we can improve human health and create new medicines for patients around the world.
This funding milestone was built on the strength of our AI drug design engine (IsoDDE), which has already proven its worth (aside from smashing benchmarks) by designing breakthrough new molecules and creating new scientific breakthroughs across our drug discovery programs.
Our IsoDDE is giving us a repeatable way to design new medicines for a wide range of diseases, building a future of medicine that we couldn’t unlock until now.
A massive thank you to our incredible team across London, Boston and Lausanne, whose relentless work made this possible, and to our partners who share our ultimate vision.
Now we have so much more to build together!